Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2022 Nov 10;12(6):e12548. doi: 10.1111/cob.12548

Comparing body mass index and obesity‐related comorbidities as predictors in hospitalized COVID‐19 patients

PMCID: PMC9877684  PMID: 36354347

In Tsoulis et al, 1 Table 4 was published with incorrect model numbers in column 1. It should read “Models 1, 2, 3” instead of “Models 4, 5, 6”. Below is the correct Table 4:

TABLE 4.

Multivariable analyses of hospitalized SARS‐CoV‐2‐infected patients with a BMI ≥25 with BMI and EOSS as categorical predictor variables

AKI ICU Admission Mechanical Ventilation Mortality
aOR 95% CI p value aOR 95% CI p value aOR 95% CI p value aOR 95% CI p value
Model 1
BMI ≥40 0.66 0.27–1.63 .368 0.64 0.30–1.37 .252 0.79 0.34–1.84 .583 2.91 0.60–14.16 .185
BMI 30.00–39.99 0.63 0.36–1.09 .0959 0.99 0.64–1.53 .953 0.92 0.56–1.53 .752 2.15 0.64–7.19 .213
BMI 25.00–29.99 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Model 2
EOSS 3/4 6.61 a 3.83–11.40 a <.001 a 17.54 5.10–60.31 <.001 3.10 a 2.01–4.76 a <.001 a 4.40 a 1.65–11.74 a .00312 a
EOSS 2 6.61 a 3.83–11.40 a <.001 a 10.86 3.28–36.01 <.001 3.10 a 2.01–4.76 a <.001 a 4.40 a 1.65–11.74 a .00312 a
EOSS 0/1 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Model 3
BMI ≥40 0.770 0.29–2.03 .600 0.69 0.32–1.52 .357 0.890 0.37–2.13 .795 3.92 0.77–19.91 .100
BMI 30.00–39.99 0.73 0.41–1.32 .297 1.00 0.64–1.57 .994 1.020 0.610–1.72 .933 2.70 0.79–9.26 .115
BMI 25.00–29.99 1 (ref) 1 (ref) 1 (ref) 1 (ref)
EOSS 3/4 6.40 a 3.71–11.05 a <.001 a 17.270 5.02–59.38 <.001 3.10 a 2.01–4.78 a <.001 a 5.05 a 1.83–13.90 a .00174 a
EOSS 2 6.40 a 3.71–11.05 a <.001 a 10.710 3.23–35.51 <.001 3.10 a 2.01–4.78 a <.001 a 5.05 a 1.83–13.90 a .00174 a
EOSS 0/1 1 (ref) 1 (ref) 1 (ref) 1 (ref)

Note: Reference groups—Overweight (BMI 25.00–29.99) for WHO Categories of BMI and EOSS stage 0/1 for EOSS stage. Bolded aORs are statistically significant.

Abbreviations: AKI, acute kidney injury; aOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; EOSS, Edmonton Obesity Staging System; ICU, Intensive Care Unit.

a

EOSS stage is considered as a continuous predictor variable due to zero counts, with the reference group being the stage below each stage examined (i.e. reference group for EOSS stage 3/4 is EOSS stage 2 and reference group for EOSS stage 2 is EOSS stage 0/1).

We apologize for this error.

REFERENCE

  • 1. Tsoulis MW, Garcia VL, Hou W, Arcan C, Miller JD. Comparing body mass index and obesity‐related comorbidities as predictors in hospitalized COVID‐19 patients. Clinical Obesity 2022;12(3):e12514. https://doi.org/ 10.1111/cob.12514 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Obesity are provided here courtesy of Wiley

RESOURCES